Psychedelic Harm Reduction and Integration in Practice

This study, published in the Frontiers in Psychology journal, presents a model for psychedelic harm reduction and integration (PHRI) in clinical practice. The model can be integrated with a variety of psychotherapy approaches so can used in existing practices.

Overall, PHRI could reduce potential harms of using psychedelics, plus enhance benefits already seen.

This model comes at a great time, given the recent surge in interest in the field. To date there is "no published peer-reviewed literature defining psychedelic integration and no cohesive, guiding model for clinicians to draw on. This paper represents the first of such models to be defined and differentiated in the academic literature."

ABSTRACT

"Psychedelic Harm Reduction and Integration (PHRI) is a transtheoretical and transdiagnostic clinical approach to working with patients who are using or considering using psychedelics in any context. The ongoing discussion of psychedelics in academic research and mainstream media, coupled with recent law enforcement deprioritization of psychedelics and compassionate use approvals for psychedelic-assisted therapy, make this model exceedingly timely.

Given the prevalence of psychedelic use, the therapeutic potential of psychedelics, and the unique cultural and historical context in which psychedelics are placed, it is important that mental health providers have an understanding of the unique motivations, experiences, and needs of people who use them. PHRI incorporates elements of harm reduction psychotherapy and psychedelic-assisted psychotherapy, and can be applied in both brief and ongoing psychotherapy interactions. PHRI represents a shift away from assessment limited to untoward outcomes of psychedelic use and abstinence-based addiction treatment paradigms and toward a stance of compassionate, destigmatizing acceptance of patients' choices. Considerations for assessment, preparation, and working with difficult experiences are presented."

For more updates on the latest psychedelic news and research, visit the psychedelic health professional network homepage.

Previous
Previous

Assessing differences in responses to ayahuasca and placebo in participants of naturalistic ayahuasca ceremonies

Next
Next

Associations between lifetime classic psychedelic use and physical health markers